GIP-Overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Kim, Su Jin ^a   Nian, Cuilan ^a   Karunakaran, Subashini ^a   Clee, Susanne M ^a   Isales, Carlos M ^b   McIntosh, Christopher H S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CALORIMETRY; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; ENERGY EXPENDITURE; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIVER FUNCTION; MACROPHAGE; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; ENERGY METABOLISM; FATTY LIVER; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN RESISTANCE; MALE; MICE; MICE, TRANSGENIC; OBESITY;

MUS; MUS MUSCULUS; RODENTIA;

EID: 84863615352     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040156     Document Type: Article

References (55)

1. Doyle M, Egan J, (2003) Pharmacological agents that directly modulate insulin secretion. Pharmacological Reviews 55: 105-131.
2. Stumvoll M, Goldstein B, van Haeften T, (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346.
3. Padwal R, Majumda S, Johnson J, Varney J, McAlister F, (2005) A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care 28: 736-744.
4. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, et al. (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. New England Journal of Medicine 355: 2427-2443.
5. Drucker DJ, (2007) The role of gut hormones in glucose homeostasis. J Clin Invest. 117: 24-32.
6. Holst JJ, (2007) The physiology of glucagon-like peptide-1. Physiol. Rev. 87: 1409-1439.
7. McIntosh CHS, Widenmaier S, Kim SJ, (2010) Pleiotropic actions of the incretin hormones. Vitam. Horm. 84: 21-79.
8. Brubaker PL, Drucker DJ, (2004) Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145: 2653-2659.
9. McIntosh CHS, Widenmaier S, Kim SJ, (2009) Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP). Vitam Horm. 80: 409-471.
10. Hinke SA, Gelling RW, Pederson RA, Manhart S, Nian C, et al. (2002) Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats. Diabetes. 51: 652-61.
11. Gault VA, Porter DW, Irwin N, Flatt PR, (2011) Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed mice. J Endocrinol. 208: 265-71.
12. Irwin N, Gault V, Flatt PR, (2010) Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease? Expert Opin Investig Drugs. 19: 1039-48.
13. Widenmaier SB, Kim SJ, Yang GK, De Los Reyes T, Nian C, et al. (2010) A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control. PLoS One. 5: e9590.
14. McIntosh CHS, Bremsak I, Lynn FC, Gill R, Hinke SA, et al. (1999) Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin. Endocrinology. 140: 398-404.
15. Kim SJ, Nian C, McIntosh CHS, (2007) Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. A role for a protein kinase B, LKB1, and AMP-activated protein kinase cascade. J Biol Chem. 282: 8557-8567.
16. Kim SJ, Nian C, McIntosh CHS, (2007) Resistin is a key mediator of glucose-dependent insulinotropic polypeptide (GIP) stimulation of lipoprotein lipase (LPL) activity in adipocytes. J Biol Chem. 282: 34139-34147.
17. Kim SJ, Nian C, McIntosh CHS, (2010) GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene. J Lipid Res 51: 3145-572010.
18. Kim SJ, Nian C, McIntosh CHS, (2011) Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation. J Lipid Res 52: 759-70.
19. Song DH, Getty-Kaushik L, Tseng E, Simon J, Corkey BE, et al. (2007) Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation. Gastroenterology. 133: 1796-805.
20. Getty-Kaushik L, Song DH, Boylan MO, Corkey BE, Wolfe MM, (2006) Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification. Obesity (Silver Spring). 14: 1124-31.
21. Mohammad S, Ramos LS, Buck J, Levin LR, Rubino F, et al. (2011) Gastric inhibitory peptide controls adipose insulin sensitivity via activation of CREB and p110β isoform of PI3 kinase. J Biol Chem. 286: 43062-70.
22. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, et al. (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nature Medicine 8: 738-742.
23. Gniuli D, Calcagno A, Dalla Libera L, Calvani R, Leccesi L, et al. (2010) High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats. Diabetologia. 53: 2233-40.
24. Irwin N, Flatt PR, (2009) Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. Diabetologia 52: 1724-1731.
25. McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, et al. (2007) GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab 293: E1746-55.
26. Althage MC, Ford EL, Wang S, Tso P, Polonsky KS, et al. (2008) Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J Biol Chem. 283: 18365-76.
27. Fulurija A, Lutz TA, Sladko K, Osto M, Wielinga PY, et al. (2008) Vaccination against GIP for the treatment of obesity. PLoS ONE 3: e3163.
28. Hinke SA, Pauly RP, Ehses J, Kerridge P, Demuth HU, et al. (2000) Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptide. J Endocrinol. 165: 281-91.
29. Xie D, Zhong Q, Ding KH, Cheng H, Williams S, et al. (2007) Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass. Bone. 40: 1352-60.
30. Sethi J, Vudal-Puig A, (2007) Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 48: 1253-1262.
31. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 117: 2621-37.
32. Ye JM, Dzamko N, Cleasby ME, Hegarty BD, Furler SM, et al. (2004) Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin. Diabetologia. 47: 1306-13.
33. Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, et al. (1999) Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A. 96: 14843-14847.
34. Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, et al. (2007) Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J Clin Invest. 117: 143-52.
35. Park J, Choe SS, Choi AH, Kim KH, Yoon MJ, et al. (2006) Increase in glucose-6-phosphate dehydrogenase in adipocytes stimulates oxidative stress and inflammatory signals. Diabetes. 55: 2939-49.
36. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, et al. (2008) Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci U S A. 105: 6531-6.
37. Kohlstedt K, Trouvain C, Namgaladze D, Fleming I, (2011) Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype. Basic Res Cardiol. 106: 205-15.
38. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello CS, et al. (2003) Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science. 299: 896-9.
39. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, et al. (2006) TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest. 116: 2791-8.
40. Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, et al. (2007) Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation. J Biol Chem. 282: 15439-50.
41. Andrews ZB, (2010) Uncoupling protein-2 and the potential link between metabolism and longevity. Curr Aging Sci. 3: 102-12.
42. Tedesco L, Valerio A, Dossena M, Cardile A, Ragni M, et al. (2010) Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. Diabetes. 59: 2826-36.
43. Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel W, et al. (2011) PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. Cancer Res. 71: 6888-98.
44. Millward CA, Desantis D, Hsieh CW, Heaney JD, Pisano S, et al. (2010) Phosphoenolpyruvate carboxykinase (Pck1) helps regulate the triglyceride/fatty acid cycle and development of insulin resistance in mice. J Lipid Res. 51: 1452-63.
45. Butler AA, Kozak LP, (2010) A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes. 59: 323-9.
46. Porter DW, Irwin N, Flatt PR, Hölscher C, Gault VA, (2011) Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice. Eur J Pharmacol. 650: 688-93.
47. Faivre E, Gault VA, Thorens B, Hölscher C, (2011) Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis. J Neurophysiol. 105: 1574-80.
48. Nyberg J, Jacobsson C, Anderson MF, Eriksson PS, (2007) Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain. J Neurosci Res. 85: 2099-119.
49. Ding KH, Zhong Q, Xie D, Chen HX, Della-Fera MA, et al. (2006) Effects of glucose-dependent insulinotropic peptide on behavior. Peptides. 27: 2750-5.
50. Kurrasch DM, Cheung CC, Lee FY, Tran PV, Hata K, et al. (2007) The neonatal ventromedial hypothalamus transcriptome reveals novel markers with spatially distinct patterning. J Neurosci. 27: 13624-34.
51. Hawke Z, Ivanov TR, Bechtold DA, Dhillon H, Lowell BB, et al. (2009) PACAP neurons in the hypothalamic ventromedial nucleus are targets of central leptin signaling. J Neurosci. 29: 14828-14835.
52. Irwin N, Green BD, Gault VA, Cassidy RS, O'Harte FP, et al. (2006) Effects on glucose homeostasis and insulin secretion of long term activation of the glucose-dependent insulinotropic polypeptide (GIP) receptor by N-AcGIP(LysPAL37) in normal mice. Peptides. 27: 893-900.
53. Kerr BD, Irwin N, O'Harte FP, Bailey CJ, Flatt PR, et al. (2009) Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties. Biochem Pharmacol. 78: 1008-16.
54. Faivre E, Hamilton A, Hölscher C, (2012) Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice. Eur J Pharmacol. 2012 Jan 15 674(2-3): 294-306.
55. Palmiter RD, Sandgren EP, Koeller DM, Brinster RL, (1993) Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol Cell Biol. 13: 5266-75.